FDA NDC Directory · JSON-LD · Markdown
NDC 70461-026 · VACCINE · INJECTION, SUSPENSION
| Generic name | INFLUENZA A VIRUS A/Missouri/11/2025 IVR-279 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Michigan/105/2025 IVR-285 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/Tokyo/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED) |
|---|---|
| Labeler / Manufacturer | Seqirus, Inc. |
| Marketing category | Biologic License Application · App BLA125510 |
| Dosage form / route | INJECTION, SUSPENSION · INTRAMUSCULAR |
| Active ingredients | INFLUENZA A VIRUS A/MISSOURI/11/2025 IVR-279 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) (15 ug/.5mL) INFLUENZA A VIRUS A/MICHIGAN/105/2025 IVR-285 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) (15 ug/.5mL) INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED) (15 ug/.5mL) |
| Marketing started | 20260701 |
| Marketing ended | 20270731 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).